POMALIDOMID Teva caps 1 mg 21 pce
7680695760026
CH-69576
L04AX06
07.16.4.
Reimbursement limitations:
POMALI.Sa.04
POMALIDOMID SANDOZ en association avec l’isatuximab et la dexaméthasone
Le traitement nécessite une garantie de …
1 / 3
google
Details
- Product number
- 6957601
- CPT
- -
- Packaging group
- 21
- Unit
- Kapsel(n)
- Composition
- pomalidomidum 1 mg, lactosum monohydricum 50 mg, crospovidonum, povidonum K 30, natrii laurilsulfas, natrii stearylis fumaras, Kapselhülle: E 133, E 171, gelatina, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.135 mg.
Articles (1)
Pomalidomid-Teva 1 mg, Hartkapseln
Kapseln
21
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
50.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.135 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 3415.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2025
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 69576
- Drug name
- Pomalidomid-Teva, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L04AX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 04/11/2024
- Authorization expiration date
- 03/11/2029
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- POMALIDOMID Teva caps 1 mg 21 pce
- Description (DE)
- POMALIDOMID Teva Kaps 1 mg 21 Stk
- Market launch
- 04/11/2024
- Narcotic (BTM)
- No